baber/WOPTO huggingface dataset:
Patent NZ-560701-A (NZ)
Title: Gravity Gradiometer with a mounting having a three part mount connected by flexure webs
Inventor: VAN KANN FRANK JOACHIM
IPC: G01V7/16
Filed: 2006-08-31
Abstract: Disclosed is a gravity gradiometer for measuring components of a gravity gradient tensor. The gradiometer comprises: a sensor (41, 42) for measuring the components of the gravity gradient tensor; and a mounting (5) for providing rotation about three substantially orthogonal axes, and for supporting the sensor. The sensor comprises a first mass (41) and a second mass (42) supported within respective first and second housings for movements relative to the housings in response to the gravitational field. The mounting comprises: a first mount (10); a second mount; and a first flexure web (33) for pivotally coupling the first and second mounts for pivotal movement about a first axis. The second mount has a first part (25), a second part (26) and a third part (27). The first part connects to the second part by a second flexure web (37) for pivotally coupling the first part to the second part for pivotal movement about a second axis orthogonal to the first axis. The third part is coupled to the second part by a third flexure web (35) for pivotally coupling the third part to the second part for pivotal movement about a third axis orthogonal to the first and second axes.
Patent NZ-566198-A (NZ)
Title: Heat exchanger
Inventor: MARSH CLIVE
Filed: 2008-02-25
Abstract: Disclosed is a shell and tube heat exchanger with a shell 2 having first and second ends 3,4, and a first and second shell chamber 5, 6, partitioned using a longitudinal baffle 7 sealing from the first distal end to prior to the second end. At least one opening 8 between the first and second shell chamber is located prior to the second end. A first and second ban of tubes 9,10, are located within the first and second shell chambers. Tube header plates 11 disposed transversely to the shell at either end are used to retain the tube banks and are divided into two halves by the longit
Patent NZ-568459-A (NZ)
Title: Use of effectors of glutaminyl and glutamate cyclases
Inventor: DEMUTH HANS-ULRICH
IPC: C07D471/04
Filed: 2004-05-05
Abstract: Disclosed is the use of an inhibitor of QC selected from the group consisting of imidazole derivatives and histamine derivatives, including all pharmaceutically acceptable salts and enantiomers thereof, in combination with an inhibitor of DP IV or DP IV-like enzymes wherein the DP IV-like enzyme is selected from the group consisting of fibroblast activation protein alpha, dipeptidyl peptidase IV beta, dipeptidyl aminopeptidase-like protein, N-acetylated alpha-linked acidic dipeptidase, quiescent cell proline dipeptidase, dipeptidyl peptidase II (DP II), attractin, DP 6, DPP 8, DPP 9, DPL2 and DPP 10, and/or an aminopeptidase-inhibitor in the manufacture of a medicament for inhibiting a) the formation of a QC substrate selected from the group consisting of Abeta3-40/42, [Gln3]Abeta3-40/42, [Glu11]Abeta11-40/42, [Gln11]Abeta11-40/42 and [Gln1]CCL 2 and, subsequently, b) the conversion of N-terminal glutamic acid or glutamine residues to pyroglutamic acid residues in said QC-substrate; for the prevention or treatment of a disease selected from Alzheimer's disease and Down's syndrome.
Patent NZ-571690-A (NZ)
Title: Ocular allergy treatments using alcaftadine
Inventor: PARASRAMPURIA JAGDISH
IPC: A61K31/55
Filed: 2007-03-26
Abstract: An ophthalmic composition that comprises alcaftidine, also known as 6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo [2,1-b] [3] benzazepine-3-carboxaldehyde (Formula I) or a compound of Formula II. The compounds are antagonists for the histamine H4 receptor. The ophthalmic compositions are used in the treatment of a symptom of ocular allergy, in particular allergic conjunctivitis or ocular inflammation.
Patent NZ-575590-A (NZ)
Title: In vivo transformation of pancreatic acinar cells into insulin-producing cells
Inventor: GRAYBURN PAUL A
IPC: C12N5/00
Filed: 2007-09-21
Abstract: Disclosed is a single construct vector for expressing betacellulin (BTC) and Pancreas Duodenum Homeobox-1 (PDX1) in the manufacture of a medicament for inducing insulin production to treat diabetes. Also disclosed is a composition comprising a microbubble capable of being destroyed upon exposure to ultrasound; and a nucleic acid expression construct that expresses betacellulin, and PDX1 when transfected into acinar cells disposed within the microbubble.
Patent NZ-575856-A (NZ)
Title: Assessing pulmonary gas transfer in lungs using hyperpolarized 129xe mri
Inventor: DRIEHUYS BASTIAAN
IPC: A61B5/055
Filed: 2007-10-02
Abstract: A method for providing MRI data of pulmonary gas exchange and/or alveolarcapillary barrier status is disclosed. The method comprises transmitting an RF MRI excitation pulse imaging sequence configured to excite dissolved phase hyperpolarized 129Xe in a gas exchange region of a lung of a subject; and generating a three-dimensional 129Xe MRI image of a gas exchange region of the lung using dissolved phase 129Xe MRI image signal replenishment data associated with both red blood cell (RBC ) compartment and a barrier compartment. The RF excitation pulse imaging sequence comprises (a) a 3-D spin echo imaging sequence whereby the 3-D spin echo sequence generates an echo at about 90 degrees phase difference between the RBC compartment and the barrier compartment signals, or (b) radial imaging such that image data of 129Xe uptake in the barrier and RBC compartments are generated 90 degrees out of phase. Further disclosed is an MRI scanner system comprising an MRI scanner comprising an MRI receiver with a plurality of channels including a first channel configured to receive 129Xe RBC signal data of an RBC compartment of a lung of a patient and a second channel configured to receive 129Xe barrier compartment signal data of the lung of the patient. The MRI scanner is configured to programmatically set an MRI scanner frequency and phase to a 129Xe dissolved phase imaging mode configured for xenon alveolarcapillary transfer imaging.
Patent NZ-583851-A (NZ)
Title: Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases
Inventor: BOSSERHOFF ANJA
IPC: A61K9/00
Filed: 2008-09-12
Abstract: Disclosed is use of a repellent factor for the manufacture of a pharmaceutical composition for the prevention and/or treatment of a cartilage defect, wherein the repellent factor is selected from SLITs.
Patent NZ-585727-A (NZ)
Title: Post Clip for retaining a wire
Inventor: RICHARDSON MARK FLETCHER
IPC: A01G17/04
Filed: 2010-04-29
Abstract: Disclosed is a post clip for fastening a wire to a post. The post clip includes a main body portion and an aperture engaging means. The main body portion has a base adapted to abut the contour of a post, a central portion extending upwardly from the base, and at least two wire engaging portions projecting outwardly from and transversely to the vertical axis of the central portion. Each wire engaging portion projects outwardly in an opposite direction relative to other wire engaging portion and each wire engaging portion has an end part that curves inwardly towards the base and the central portion so as to define a wire engaging aperture that is adapted to capturing, retaining and supporting a part of elongate strand member therein. The aperture engaging means extends outwardly and downwardly from the base of the main body portion. The aperture engaging means is dimensioned and configured to fit within and retain the post clip in a non-circular aperture in the post. (62) Divided Out of 577942
Patent NZ-586651-A (NZ)
Title: 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
Inventor: BRAJE WILFRIED
IPC: A61K31/4545
Filed: 2008-12-05
Abstract: Disclosed is a compound of formula (I) where the substituents are: R1 is hydrogen, methoxy or ethoxy; R2 is hydrogen or methoxy; R3 is hydrogen, methyl, ethyl, n-propyl or isopropyl; R4 is ethoxy or isopropoxy; R5 is H or methyl; R6 is Cl or F; X1 is 0, NH or CH2; and X2 and X3 are N or CH, with the proviso that X2 and X3 are not simultaneously N; and their pharmaceutically acceptable salts and prodrugs thereof. Examples of compounds of formula (I) are: (+/-)-4-(1-Methylpiperidin-4-yl)piperazine-1-(1-phenylsulfonyl-5-chloro-3-(2-ethoxypyrdin-3-yl)-2-oxo-2,3-dihydro-1H-indol-3-yl)carboxamide, trifluoroacetic acid salt; (+/-)-4-(1-Ethylpiperidin-4-yl)piperazine-1-( 5-chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-ethoxypyrdin-3-yl)-2-oxo-2,3-dihydro-1H -indol-3-yl)carboxamide; (+/-)-4-( 4-Methylpiperazin-1-yl)piperidine-1-( 5-chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-ethoxypyrdin- 3- yl)- 2-oxo- 2,3 -dihydro-1H-indol- 3-yl) carboxamide. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for the treatment and/or prophylaxis of vasopressin-dependent diseases such as hypertension, pulmonary hypertension, heart failure, myocardial infarction, coronary spasm, unstable angina, PTCA (percutaneous transluminal coronary angioplasty), ischemias of the heart, impairments of the renal system, edemas, renal vasospasm, necrosis of the renal cortex, hyponatremia, hypokalemia, Schwartz-Barter syndrome, impairments of the gastrointestinal tract, gastritic vasospasm, hepatocirrhosis, gastric and intestinal ulcers, emesis, emesis occurring during chemotherapy, and travel sickness.
Patent NZ-594281-A (NZ)
Title: Means and methods for modulating notch3 protein expression and/or the coding region of notch3; compositions and use thereof in the treatment of cadasil
Inventor: LESNIK OBERSTEIN SASKIA ANNE-MARIE JENNY
IPC: C07K14/705
Filed: 2010-01-26
Abstract: NZ 594281 Disclosed is the use of an anti-sense oligonucleotide for a NOTCH3 pre-mRNA for the preparation of a medicament for the treatment of a disease or disorder resulting from mutant NOTCH3 expression, wherein said NOTCH3 pre-mRNA encodes a mutant NOTCH3 protein having an EGFL repeat with an uneven number of cysteine residues, and wherein said anti-sense oligonucleotide is complementary to and hybridises with said pre-mRNA and thereby induces the exclusion of one or more EGFL-repeat coding exons selected from exon 2 to 23 from mRNA produced from said pre-mRNA, thereby producing an mRNA encoding a NOTCH3 protein having EGFL repeats with even numbers of cysteine residues.
Patent NZ-599383-A (NZ)
Title: Greenhouse and forced greenhouse climate control system and method
Inventor: REINDERS GEURT
IPC: A01G9/24
Filed: 2010-05-07
Abstract: 599383 A greenhouse air distribution system providing uniform airflow is disclosed. The system comprises a plurality of tubes (200) to distribute air. The tubes (200) comprise an inner tube (204) within an outer tube (202). A main air flow is supplied to the interior of at least one of the inner tubes (204) and the air pressure within the inner tube varies along its length. The tube comprises inner tube holes (208) to allow air to pass from the inner tube (204) to the outer tube (202) and outer tube holes (206) to allow air to pass into the greenhouse. The inner (204) and outer (202) tube holes are offset from each other. The inner and outer tube holes are configured to provide for a substantially uniform air distribution into the greenhouse along their lengths.
Patent NZ-605150-A (NZ)
Title: Ozone distribution system and method
Inventor: HASELHOFF DIRK HEMO
IPC: A01G7/02
Filed: 2011-10-05
Abstract: Ozone is added to a gas such as air which is pumped through a series of ducts then released into the air surrounding the plants growing in an outdoor environment such as an outdoors orchard. The method is said to effectively combat Pseudomonas syringae pv actinidiae (PSA) infection in kiwifruit vines and may also assist in reducing insect infestation of the plants.
Patent NZ-605885-A (NZ)
Title: Methods for rapid multiplexed amplification of target nucleic acids
Inventor: LAM HEUNG C
IPC: B01L7/00
Filed: 2008-04-04
Abstract: 605885 Disclosed is a thermal cycler system with a temperature control element (TCE) having a first surface, a substrate comprising a sample chamber comprising a solution the sample chamber positioned in thermal communication with the first surface, and a sensing chamber comprising a thermosensor. The sensing chamber is fabricated to have the same material stack-up as the sample chamber and configured and positioned in the substrate at an analogous position to that of the sample in the sample chamber so as to simulate the conditions within the sample chamber. A controller receives input from the thermosensor which then provides feedback to heat or cool the TCE to set or maintain the solution in the sample chamber at a desired temperature.
Patent NZ-606359-A (NZ)
Title: Fibres, a process for producing such fibres and a wound dressing incorporating them
Inventor: BALLAMY LUCY LOUISA
IPC: A61L26/00
Filed: 2011-07-22
Abstract: Disclosed are multi component fibres for the reduction of the damaging activity of wound exudate components such as protein degrading enzymes and inflammatory mediators in wounds, the fibres comprising: from 10% to 100% by weight of the fibres of pectin and a sacrificial proteinaceous material in a weight ratio of 80:20 to 60:40 pectin to sacrificial proteinaceous material; from 0% to 90% by weight of the fibres of another polysaccharide or a water soluble polymer; and divalent ions such as calcium, zinc, magnesium, copper, or iron.
Patent NZ-608830-A (NZ)
Title: Streaming light propagation
Inventor: BURLEY BRENT
IPC: G06T15/06
Filed: 2013-03-28
Abstract: Disclosed is a computing device for providing streaming light propagation. The computing device is comprised of a processor. The processor is configured to record a plurality of light propagation records (264a-264d) in a scene and determine a plurality of light emission samples (262) in the scene. The processor is also configured to edit the plurality of light emission samples (262) and generate an output image by propagating the plurality of light emission samples (262) through the plurality of light propagation records (264a-264d).
Patent NZ-617824-A (NZ)
Title: Improved peptide pharmaceuticals for insulin resistance
Inventor: NESTOR JOHN J
IPC: C07K14/605
Filed: 2012-05-17
Abstract: The disclosure relates to glucagon derivates comprising a surfactant. The surfactant may be N-omega-1’-alkyl beta-D-glucuronyl and it may be covalently linked to a lysine. The disclosure also relates to pharmaceutical compositions comprising these peptides and the use of them in the treatment of diseases such as diabetes or cardiovascular disease.
Patent NZ-622508-A (NZ)
Title: Control method for an electrical hair removal device
Inventor: YOKO OGUCHI
IPC: A45D26/00
Filed: 2014-03-14
Abstract: A control method for an electrical hair removal device and the device it controls is disclosed. The electrical hair removal device includes a heat generator (1071) having a heating wire used to remove the hair. The method includes the steps of starting the electrical hair removal device and let it go into a standby state; placing the heat generator on an area of skin where removal of hair is desired and electrifying the heating wire to a predetermined temperature. The wire does not heat until it is close to the skin. This is controlled either by the heat generator being displaced by skin contact so that an electrical connection is formed to supply power to the wire or by the displacement triggering a signal from an opto-sensor to turn on the power.
Patent NZ-623282-A (NZ)
Title: A support assembly for use in a storage system
Inventor: NILSSON PETER
IPC: A47B96/06
Filed: 2012-10-25
Abstract: A support assembly for use in a storage system, the assembly comprising a holding device and a bracket. The bracket is adapted to be connected to a vertical carrier element in order to be able to support a shelf in a cantilevered fashion, and has a U-shaped cross-section. The holding device comprises a connecting part (13) and a holding part (15). The connecting part is bent along a line to form, in cross-section, a U-shape having a first and a second leg (19, 21). The first leg is adapted to be inserted into the U-shape of the bracket and the second leg is connected to the holding part having a holding feature.
Patent NZ-624601-A (NZ)
Title: Reduction of galectin-3 levels by plasmapheresis
Inventor: ELIAZ ISAAC
IPC: G01N33/53
Filed: 2012-09-28
Abstract: The disclosure relates to the removal of serum gal-3 from circulation by plasmapheresis using gal-3 binding agents in either a fixed bed, or in a form easily removed, such as by being complexed with magnetic particles. This method, on its own, brings a sharp reduction and relief from the inflammation and fibroses that can be induced by circulating gal-3. The process may be combined with the administration of gal-3 binding agents, such as modified citrus pectin, to further lower unbound gal-3 levels, to the point where gal-3 in the tissues may be addressed. This method may also be combined with removal of TNF receptors to provide an effective treatment for cancer. Particularly disclosed is the use of a gal-3 binding molecule in the preparation of a medicament for treating a condition in a mammal mediated at least in part by active galectin-3 in the blood, wherein the medicament is formulated for conducting plasmapheresis on blood obtained from the mammal; and wherein the medicament selectively removes galectin-3 (gal-3) by contact with said gal-3 binding molecule of the medicament, such that at least ten percent of the gal-3 in serum of the mammal is removed by said plasmapheresis.
Patent NZ-631063-A (NZ)
Title: Texture analysis of a coated surface using cross-normalization
Inventor: NORRIS ALISON M
IPC: G06F17/18
Filed: 2014-09-11
Abstract: Spectroscopic reflectance data from a target coating is used to calculate cross or pivot-normalized reflectance data which is helpful to ascertain a coating formulation that will provide the same appearance as the target coating. The reflectance data includes arrays of wavelength data and arrays of angle data. The pivot normalized reflectance data is calculated using a z-score pivot on the basis of the wavelength array of the reflectance data. The pivot normalized reflectance data from the target coating is compared to correspondingly pivot normalized reflectance data stored within an empirical data set, and on the basis of this comparison the processor generates a coating formulation that is of the same or similar appearance to that of the target coating.
Patent NZ-631779-A (NZ)
Title: Improvements in and relating to a fishing system
Inventor: ROBERT HAMILTON HALL
IPC: B63B1/24
Filed: 2013-12-12
Abstract: A fishing system (1) particularly for catching fish or crab on a trotline is disclosed. The system includes a primary baited fishing line (2) and at least one catching means (8). The catching means (8) including a collector such as a net is suspended from the primary line (2) in the body of water being fished. The catching means (8) is directed along the primary line (2) such as by a boat (9). The primary line (2) passes through the catching means (8) which effects release of the target species from the line into a net or cage.
Patent NZ-706325-A (NZ)
Title: Compact pneumatic nailer with supplemental air tank
Inventor: SCHIELER BRYAN
IPC: F15B1/027
Filed: 2013-09-17
Abstract: A pneumatic nailer system (10) for use with a compressor (13) having a main storage tank, includes a first air hose (26) connected at one end to the compressor (13), a supplemental air storage tank (12) connected to an opposite end of the first hose (26), and connected at a supply end to at least one second air hose (44), a pneumatic nailer (14) connected to a tool end of the at least one second air hose (44), such that the supplemental air storage tank (12) is located between the compressor (13) and the at least one nailer (14). The supplemental air storage tank (12) enables the pneumatic nailer(s) connected to the supplemental air storage tank (12) to provide consistent drive energy for driving fasteners while reducing the internal air storage volume and overall size of the nailer (14).
Patent NZ-712896-A (NZ)
Title: Sliding door
Inventor: NILSSON PETER
IPC: E05F1/16
Filed: 2014-04-07
Abstract: The present inventions seeks to improve the smooth operation of a sliding door and improve the longevity while retaining a reliable attenuation and retraction functionality. The present disclosure relates to sliding door, intended for use with a rail system, having a rail, which guides a sliding motion of the door, and an attenuation and retraction device, which brakes the sliding motion of the door at a brake position in the vicinity of a door end position and retracts the door to the end position. The sliding door comprises a pin, which is slideably attached to the door, slideable between a retracted position and an extended position, a tip of the pin being devised to interact with the attenuation and retraction device. The door further comprising a wheel carried by a wheel holder, which is arranged to move the wheel between a retracted position and an extended position.A transmission mechanism interconnects the wheel holder and the pin such that a movement of the wheel, towards the extended position of the wheel, urges the pin towards the extended position.
Patent NZ-717629-A (NZ)
Title: Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
Inventor: RABOISSON PIERRE JEAN-MARIE BERNARD
IPC: A61K31/445
Filed: 2014-10-22
Abstract: Inhibitors of HBV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R1 to R7 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
Patent NZ-720860-A (NZ)
Title: Optical system and lighting device comprised thereof
Inventor: YODER BENJAMIN LEE
IPC: F21V13/04
Filed: 2013-01-30
Abstract: Disclosed is a lighting device. The lighting device comprises a light source (102) with a plurality of light emitting devices (104) and a beam forming optical system. The light source aligned on an optical axis (106). The beam forming optical system (108) forms light from the light source (102) into a light beam (110). The beam forming optical system (108) comprises an optical element having a plurality of focus points (126, 128). At least one of which is spaced apart from the optical axis (106) and falls outside of an imaging region (136) having a boundary (134) spaced apart from the light source (102).
Patent NZ-721308-A (NZ)
Title: Dry powder inhaler
Inventor: KEEGSTRA JOHAN
IPC: A61K31/167
Filed: 2014-11-19
Abstract: This invention provides a budesonide/formoterol dry powder inhaler (10) comprising: a reservoir (14) containing a dry powder medicament and an arrangement for delivering a metered dose of the medicament from the reservoir; a cyclone deagglomerator (10’) for breaking up agglomerates of the dry powder medicament; a delivery passageway (34) for directing an inhalation-induced air flow through a mouthpiece (24), the delivery passageway extending to the metered dose of medicament, wherein the medicament comprises micronised formoterol fumarate, micronised budesonide and a lactose carrier, the lactose carrier having a particle size distribution of d10 equals 20-65 microns, d50 equals 80-120 microns, d90 equals 130-180 microns and less than 10 microns equals less than 10%.
Patent NZ-729870-A (NZ)
Title: Liner film
Inventor: DIMITRIS GKINOSATIS
IPC: C08L77/00
Filed: 2017-03-08
Abstract: The invention relates to gusseted plastic film with a thickness of 50 to 200 microns, comprising a polyolefin homopolymer or copolymer, a polyether copolymer and a layer comprising oxygen barrier polymer.